Two copper(II) complexes of curcumin derivatives: synthesis,crystal structure and in vitro antitumor activity

Two Cu(II) complexes of curcumin derivatives, formulated as CuL ₂ ^a (1) and CuL ₂ ^b (2) [HL^a = 1,7-bis(4-ethyloxy-3-methoxy-phenyl)-1,6-heptadiene-3,5-dione and HL^b = 1,7-bis(4-butyloxy-3-methoxy-phenyl)-1,6-heptadiene-3,5-dione], have been synthesized and characterized by single-crystal X-ray diffraction, along with physicochemical and spectroscopic methods. In both complexes, each Cu(II) center is surrounded by four oxygen atoms from two β-diketone ligands in a square planar geometry. Complex 1 forms a 2D layer structure through intermolecular π–π stacking interactions, as well as weak coordination interactions between the Cu and O atoms of the solvent 1,4-dioxane molecules. Complex 2 displays a 1D column structure stabilized by intermolecular π–π stacking interactions. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assays were used to evaluate the cytotoxicities of these complexes against three human cancer cell lines. The results show that the Cu(II) complexes exhibit more potent inhibition tumor growth in comparison with the free ligands.     

Synthesis,characterization and antitumour activities of some synthetic curcuminoid analogues and their copper complexes

The cytotoxic and antitumour activities of four curcuminoid analogues, namely 1,7-diphenyl-1,6-heptadiene-3,5-dione (HL¹), 1,7-bis(4-methoxyphenyl)-1,6-heptadiene-3,5-dione (HL²), 1,7-bis(3,4-dimethoxyphenyl)-1,6-heptadiene-3,5-dione (HL³), 1,7-bis(3,4-dihydroxyphenyl)-1,6-heptadiene-3,5-dione (HL⁴) and their Cu^II complexes were investigated.The Cu complexes were found to be more active as antitumour agents compared to the free curcuminoids, in both in vitro studies and in increasing the life span of tumour bearing mice. The synthesis and characterization of the curcuminoid analogues and their Cu^II chelates employing u.v., i.r., ¹ H-n.m.r., e.s.r. and mass spectral studies are also included in this report.     

Synthesis,characterization, and antitumour studies of some curcuminoid analogues and their aluminum complexes

Aluminum(III) complexes of three curcuminoid analogues [1,7-diphenyl-1,6-heptadiene-3,5-dione, HL¹; 1,7-bis(2-hydroxyphenyl)-1,6-heptadiene-3,5-dione, HL²; and 1,7-bis(4-ethoxyphenyl)-1,6-heptadiene-3,5-dione, HL³] of [AlL₃] stoichiometry were synthesized and characterized by UV, IR, ¹H NMR, and mass spectral data. The compounds were investigated for cytotoxic and antitumor activities. The aluminum chelates are remarkably active compared to free curcuminoid analogues. The aluminum complex of HL² with hydroxyl in the phenyl ring was most active towards Ehrlich ascites carcinoma cells (concentration needed for 50% inhibition of 5?μg/mL) and cultured L929 cells (1?μg/mL produced 60?+?3% cell death). Increase in lifespan and reduction of solid tumor volume in mice were also largest for the aluminum complex of HL². The study reveals that the antitumor activities of curcuminoids are more enhanced by complexation with aluminum than with transition metal ions.     

Metal complexes of a novel bis-β-diketone-type ligand and its copper(II) complexes of two-photon biological imaging

A curcumin derivative ligand,1,7-bis(3-methoxyl-4-acetoxyl)phenyl-1,6-heptadiene-3,5-diketone (diacetylcurcumin,abbreviated as HL),and its Cu and Ni complexes have been synthesized and fully characterized by elemental analyses,IR,1 HNMR and molar conductivity.The resulting complexes exhibit two-photon excited fluorescence (TPEF) in DMF,and have been proven to be potentially useful for two-photon microscopy imaging in living cells.In addition,cytotoxicity tests showed that the low-micromolar concentrations of ML 2 did not cause significant reduction in cell viability over a period of at least 24 h and should be safe for further biological studies.     

DNA binding,DNA cleavage,and cellular imaging of a copper(II) complex based on curcumin

Binding property between CT-DNA and a Cu(II) complex, namely CuL₂, where HL = 1,7-bis(4-butoxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione, was determined by UV–Vis absorption, fluorescence spectroscopy, and viscosity measurements. The results showed that the binding of the complex with CT-DNA was through the intercalative mode and the binding constant (K_b) value was found to be 3.82 × 10⁴ M. DNA cleavage studies showed that CuL₂ exhibited effective cleavage activity on pBR322 plasmid DNA in absence of external agents. Additionally, cellular imaging studies also indicated that CuL₂ has a higher toxicity to MCF-7 cell lines compared with its corresponding ligand HL.     

Metallkomplexe von Farbstoffen. VIII Übergangsmetallkomplexe des Curcumins und seiner Derivate

Metal Complexes of Dyes. IX. Transition Metal Complexes of Curcumin and Derivatives The bidentate monoanions of curcumin[CU, (1, 7-bis(4-hydroxy-3-methoxyphenyl)-hepta-1,6-diene-3,5-dione)], diacetylcurcumin[DACU, (1,7-bis(4-acetyl-3-methoxyphenyl)-hepta-1,6-diene-3,5-dione)], dihydroxycurcumin[DHCU, (1,7-bis(4-hydroxiphenyl)-hepta-1,6-diene-3,5-dione)], dimethylcurcumin [DMCU, (1,7-bis(3,4-dimethoxyphenyl)-hepta-1, 6-diene-3,5-dione)] and trimethylcurcumin[TMCU, (1,7-bis(3,4-dimethoxyphenyl)-4-methylhepta-1,6-diene-3,5-dione)] form with chloro bridged complexes [(R₃P)MCl₂]₂ (M?Pd, Pt; R?phenyl, n-butyl, ethyl, tolyl), [η⁵-C₅Me₅)MCl₂]₂ (M?Rh, Ir), [(η⁶-p-cymene)RuCl₂]₂, [(η³-C₃H₅)PdCl]₂, di-μ-chlorobis[N-(diphenylmethylene)-glycinethylester-(C,N)]-dipalladium(II) and with [(η⁵-C₅Me₅)Co(CO)I₂] monochelate dye complexes. The structure of [(η⁶-p-cymene)(Cl)Ru(DMCU)] was determined by X-ray diffraction. The dichelates (DMCU)₂M with M?Cu, Ni, (CU)₂Pd and the trichelate (CU)₃Fe were obtained. Cationic bipyridine copper(II) complexes with CU, DHCU, and DMCU were sythesized by treating the dye ligands with copper(II) acetate, 2,2′-bipyridine and ammoniumtetrafluoroborate. In comparison to the free 1.3-diketones the dye complexes show a bathochromic shift in the UV/VIS spectra.     

Novel Bis-β-diketone-type Ligand and Its Copper and Zinc Complexes for Two-photon Biological Imaging

A curcumin derivative ligand, 1,7-bis(3-methoxyl-4-oxyethylacetate)phenyl-1,6-heptadiene-3,5-diketone (diethyl acetatecurcumin, abbreviated as HL), and its Cu(II) and Zn(II) complexes have been synthesized and characterized by elemental analyses, infrared(IR), ¹H NMR and molar conductivity. The experimental results show that the resulting complexes bear strong two-photon excited fluorescence(TPEF) in N,N-dimethyformamide solvent, which has been proven to be potentially useful for two-photon microscopy imaging in living cells. In addition, cytotoxicity tests show that the low-micromolar concentrations of metal-ligand complex(ML₂) did not cause significant reduction in cell viability over a period of, at least, 24 h and should be safe for further biological studies.     

Synthesis and characterization of copper(II) and cobalt(II) complexes with two new potentially hexadentate Schiff base ligands. X-ray crystal structure determination of one copper(II) complex

Two new potentially hexadentate N₂O₄ Schiff base ligands 2-((z)-(2-(2-(2-((z)-3,5-di-tert-butyl-2-hydroxybenzylideneamino) phenoxy) phenoxy) phenylimino) methyl)-4,6-di-tert-butylphenol [H₂L¹] and 2-((z)-(2-(2-(2-((z)-3,5-di-tert-butyl-2-hydroxybenzylideneamino) phenoxy)-5-tert-butylphenoxy) phenylimino) methyl)-4,6-di-tert-butylphenol [H₂L²] were prepared from the reaction of 3,5-di-tert-butyl-2-hydroxy benzaldehyde with 1,2-bis(2′-aminophenoxy)benzene or 1,2-bis(2′-aminophenoxy)-4-t-butylbenzene, respectively. From the direct reaction of ligands [H₂L¹] and [H₂L²] with copper(II) and cobalt(II) salts in methanolic solution and in the presence of N(Et)₃ the neutral [CuL¹], [CuL²], [CoL¹] and [CoL²] complexes were prepared. All complexes were characterized by IR spectra, elemental analysis, magnetic susceptibility, mass spectra, molar conductance (Λ_m), UV-Vis spectra and in the case of [CuL²] with X-ray diffraction. X-ray crystal structure of [CuL²] showed that the complex contains copper(II) in a distorted square planar environment of N₂O₂ donors. Three CH/π interactions were observed in the molecular structure of latter complex.     

Synthesis and mesomorphism behaviour of chalcones and pyrazoles type compounds as photo-luminescent materials

The following organic and organic–inorganic hybrid compounds were prepared as photo-luminescent materials following efficient and practical synthetic methods: 1,3-bis[4-(n-alkoxy)phenyl]-2-propen-1-one (where, n-alkoxy: O(CH₂)_nH, n = 6,7,8,9 or 10); 3,5-bis[4-(n-alkoxy)phenyl]-1H-pyrazole (where, n-alkoxy: O(CH₂)_nH, n = 6,7,8,9 or 10) (in case of n = 7, a mixture of 3,5-bis(4-heptyloxyphenyl)-1H-pyrazole and 3,5-bis(4-heptyloxyphenyl)-4H-pyrazole was detected) and bis(3,5-bis [4-(n-alkoxy) phenyl]-1H-pyrazole) silver(I) nitrate (where, n-alkoxy: O(CH₂)_nH, n = 6,7,8,9 or 10). The prepared compounds have been characterised and their structures were elucidated depending upon (FTIR, UV-Vis, ¹HNMR, ¹³CNMR, 2D ¹H-¹H-COSY, 2D ¹H-¹³C-HSQC and mass spectra) in addition to molar conductivity measurements for silver(I) complexes. The mesomorphism behaviour of the prepared compounds was studied using polarised light optical microscopy and confirmed with differential scanning calorimetry and X-ray powder diffraction techniques. The studies showed that among all of these compounds only the pyrazole derivatives are liquid crystal materials. The luminescent properties of all the prepared compounds were also investigated which confirmed that all of these compounds are photo-luminescent in the crystalline solid state and in the mesophase.     

Copper(II) azide complexes with mono-anionic tridentate Schiff-base ligands: monomer versus dimer

Three new copper(II) complexes [CuL¹N₃]₂ (1), [CuL²N₃] (2) and [CuL³N₃] (3) with three very similar tridentate Schiff base ligands [HL¹?=?6-diethylamino-3-methyl-1-phenyl-4-azahex-3-en-1-one, HL²?=?6-amino-3-methyl-1-phenyl-4-azahex-3-en-1-one and HL³?=?6-amino-3-methyl-1-phenyl-4-azasept-3-en-1-one] have been synthesized and structurally characterized by X-ray crystallography. In complex 1 half of the molecules are basal-apical, end-on azido bridged dimers and the remaining half are square-planar monomers whereas all the molecules in complexes 2 and 3 are monomers with square-planar geometry around Cu(II). A competition between the coordinate bond and H-bond seems to be responsible for the difference in structure of the complexes.     

Copper(II) complexes of N(4)-substituted thiosemicarbazones derived from pyridine-2-carbaldehyde: Crystal structure of a binuclear complex

Ten copper(II) complexes {[CuL¹Cl] (1), [CuL¹NO₃]₂ (2), [CuL¹N₃]₂ · 2/3H₂O (3), [CuL¹]₂(ClO₄)₂ · 2H₂O (4), [CuL²Cl]₂ (5), [CuL²N₃] (6), [Cu(HL²)SO₄]₂ · 4H₂O (7), [Cu(HL²)₂] (ClO₄)₂ · 1/2EtOH (8), [CuL³Cl]₂ (9), [CuL³NCS] · 1/2H₂O (10)} of three NNS donor thiosemicarbazone ligands {pyridine-2-carbaldehyde-N(4)-p-methoxyphenyl thiosemicarbazone [HL¹], pyridine-2-carbaldehyde-N(4)-2-phenethyl thiosemicarbazone [HL²] and pyridine-2-carbaldehyde N(4)-(methyl), N(4)-(phenyl) thiosemicarbazone [HL³]} were synthesized and physico-chemically characterized. The crystal structure of compound 9 has been determined by X-ray diffraction studies and is found that the dimer consists of two square pyramidal Cu(II) centers linked by two chlorine atoms.     

Complexes of Cu(II) and Pd(II) with 2-R-1,3,11,11<Emphasis Type="Italic">c</Emphasis>-tetraazacyclopenta[<Emphasis Type="Italic">c</Emphasis>]phenanthrenes

Paramagnetic complexes CuL¹SO₄·0.5H₂O, CuL²SO₄·2H₂O and diamagnetic Pd(HL²)Cl₃ (L¹ = 2-methyl-1,3,11,11c-tetraazacyclopenta[c]phenanthrene complex (L² = 2-phenyl-1,3,11,11c-tetraazacyclopenta-[c]phenanthrene) were synthesized. The most probable structure of the complexes was suggested on the basis of the IR and ESR spectra. Coordination units of paramagnetic complexes contain N atoms of the bidentate cycle-forming ligands, L¹ and L² molecules. The square PdCl₃N unit of the diamagnetic complex includes the N atom of the triazole fragment of the monodentate ligand, (HL²)⁺ cation.     

Copper(II) complexes with singly condensed tridentate Schiff-base ligands incorporating 1-benzoylacetone

Two copper(II) complexes [CuL¹Cl]_n (1) and [CuL²Cl] (2) with singly condensed tridentate Schiff-base ligands [HL¹ = 6-amino-3-methyl-1-phenyl-4-azahex-3-en-1-one and HL² = 6-diethylamino-3-methyl-1-phenyl-4-azahex-3-en-1-one] have been synthesized and structurally characterized by X-ray crystallography. Complex 1 is a single-chloro-bridged one-dimensional polymer, whereas 2 is a monomeric square-planar complex. The H-bonding interactions of the amine hydrogen and the non-bonding interactions of phenyl groups in the Schiff base play important roles for the structural variations.     

Crystal structures and in vitro anticancer studies on new unsymmetrical copper(II) Schiff base complexes derived from meso-1,2-diphenyl-1,2-ethylenediamine: a comparison with related symmetrical ones

Two new unsymmetrical copper(II) Schiff base complexes, [CuLⁿ(py)]ClO₄ (n = 1, 2) in which Lⁿ represents a tridentate N₂O type Schiff base ligand, were synthesized. Lⁿs were derived from monocondensation of meso-1,2-diphenyl-1,2-ethylenediamine with salicylaldehyde or 3-methoxysalicylaldehyde. The reaction between [CuLⁿ(py)]ClO₄ and other salicylaldehyde derivatives resulted in new N₂O₂ unsymmetrical tetradentate Cu^II complexes, CuL^3–6. Crystal structures of [CuL¹(py)]ClO₄, CuL⁴, and CuL⁵ were obtained. These new complexes as well as a series of related symmetrical ones (i.e. CuL^7–12) were tested for their in vitro anticancer activity against human liver cancer cell line (Hep-G2) by MTT and apoptosis assay. All of the complexes showed considerable cytotoxic activity against tumor cell lines (IC₅₀ = 5.13–16.24 μg mL^?1). The symmetrical CuL⁷ was the most potent anticancer derivative (IC₅₀ = 5.13 μg mL^?1) compared to the control drug 5-FU (IC₅₀ = 5.4 μg mL^-1, p < 0.05). Flow cytometry experiments showed that the copper derivatives especially [CuL²(py)]ClO₄ and CuL⁷ induced more apoptosis on Hep-G2 tumor cell lines compared to 5-FU.     

Study of the interaction between ruthenium(II) complexes and CT-DNA: synthesis,characterisation, photocleavage and antimicrobial activity studies

Two polypyridyl ligands 6-fluro-3-(1H-imidazo [4,5-f] [1,10]-phenanthroline-2-yl)-4H-chromen-4-one (FIPC), 6-chloro-3-(1H-imidazo [4,5-f] [1,10]-phenanthroline-2-yl)-4H-chromen-4-one (ClIPC) polypyridyl ligands and their Ru(II) complexes [Ru(bipy)₂FIPC]²⁺(1), [Ru(dmb)₂FIPC]²⁺(2), [Ru(phen)₂FIPC]²⁺(3), [Ru(bipy)₂ClIPC]²⁺(4), [Ru(dmb)₂ClIPC]²⁺(5) and [Ru(phen)₂ClIPC]²⁺(6) ((bipy = 2,2′-bipyridine, dmb = 4,4′-dimethyl-2,2′-bipyridine and phen = 1,10-phenanthroline) have been synthesised and characterised by elemental analysis, Mass spectra, IR, ¹H and ¹³C-NMR. The DNA-binding of the six complexes to calf-thymus DNA (CT-DNA) has been investigated by different spectrophotometric, fluorescence and viscosity measurements. The results suggest that 1–6 complexes bind to CT-DNA through intercalation. The variation in binding affinities of these complexes is rationalised by a consideration of electrostatic, steric factors and nature of ancillary ligands. Under irradiation at 365 nm, the three complexes have also been found to promote the photocleavage of plasmid pBR 322 DNA. Inhibitor studies suggest that singlet oxygen (¹O₂) plays a significant role in the cleavage mechanism of Ru(II) complexes. Thereby, under comparable experimental conditions [Ru(phen)₂FIPC]²⁺(3), [Ru(phen)₂ClIPC]²⁺(6) cleaves DNA more effectively than 1, 2, 4 and 5 complexes do. The Ru(II) polypyridyl complexes (1–6) have been screened for antimicrobial activities.     

Control of molecular architecture by hydrogen bonding: mononuclear versus dinuclear copper(II) complexes with tridentate N2O donor Schiff base isomers

Two isomeric Schiff bases, HL ¹  = 1-[(2-dimethylamino-ethylimino)-methyl]-naphthalen-2-ol and HL ²  = 1-[(2-ethylamino-ethylimino)-methyl]-naphthalen-2-ol, have been used to prepare copper(II) complexes in presence of thiocyanate. HL ¹ forms a mononuclear complex [Cu(L ¹ )NCS] with terminal thiocyanate, whereas the isomeric Schiff base HL ² , which is capable of hydrogen bonding, gives a dimeric complex, [Cu₂ (L ² ) ₂(NCS)₂], with double μ-1,1-NCS bridges. Both complexes are characterized by physico-chemical and spectroscopic methods as well as by single crystal X-ray diffraction studies.     

Ni(II) and Cu(II) complexes of new unsymmetrical N2O2 Schiff bases derived from 3-(2-aminobenzylimino)-1-phenylbutan-1-ol: synthesis,structure, antibacterial properties,and electrochemistry

Two new N₂O₂ unsymmetrical Schiff bases, H₂L¹ = 3-[({o-[(E)-(o-hydroxyphenyl)methylideneamino]phenyl}methyl)imino]-1-phenyl-1-buten-1-ol and H₂L² = 3-[({o-[(E)-(2-hydroxy-1-naphthyl)methylideneamino]phenyl}methyl)imino]-1-phenyl-1-buten-1-ol, and their copper(II) and nickel(II) complexes, [CuL¹] (1), [CuL²] (2), [NiL¹] (3), and [NiL²] (4), have been synthesized and characterized by elemental analyses and spectroscopic methods. The crystal structures of these complexes have been determined by X-ray diffraction. The coordination geometry around Cu(II) and Ni(II) centers is described as distorted square planar in all complexes with the CuN₂O₂ coordination more distorted than the Ni ones. The electrochemical studies of these complexes indicate a good correlation between the structural distortion and the redox potentials of the metal centers. The ligand and metal complexes were also screened for their in vitro antibacterial activity.     

Synthesis,spectral, thermal and crystallographic investigations on oxovanadium(IV) and manganese(III) complexes derived from heterocyclic β-diketone and 2-amino ethanol

Novel mononuclear oxovanadium(IV) and manganese(III) complexes [VO(L¹)₂·H₂O] (1); [VO(L²)₂·H₂O] (2); [VO(L³)₂·H₂O] (3); [Mn(L¹)₂]ClO₄·H₂O (4); [Mn(L²)₂] ClO₄·H₂O (5); [Mn(L³)₂]ClO₄·H₂O (6) were prepared by condensation of 1 mol of VOSO₄·5H₂O or Mn(OAc)₃· 2H₂O with 2 mol of ligand HL¹, HL² or HL³ (where HL¹ = 4-[(2-hydroxy-ethylamino)-methylene]-5-methyl-2- phenyl-2,4-dihydro-pyrazol-3-one; HL²=4-[(2-hydroxy-ethylamino)-methylene]-5-methyl-2-p-tolyl-2,4-dihydro-pyrazol-3-one; HL³=4-{4-[(2-hydroxy-ethyl-amino)-methyl]-3-methyl-5-oxo-4,5-dihydropyrazol-1-yl} benzene sulfonic acid). The resulting complexes were characterized by elemental analyses, molar conductance, magnetic and decomposition temperature measurements, electron spin resonance, FAB mass, IR and electronic spectral studies. From TGA, DTA and DSC, the thermal behaviour and degradation kinetic were studied. Electronic spectra and magnetic susceptibility measurements indicate distorted octahedral stereochemistry of oxovanadium(IV) complexes and regular octahedral stereochemistry of manganese(III) complexes. Hamiltonian and bonding parameters found from ESR spectra indicate the metal ligand bonding is partial covalent. The X-ray single crystal determination of one of the representative ligand was carried out which suggests existence of amine-one tautomeric form in the solid state. The ¹H-NMR spectra support the existence of imine-ol form in solution state. The LC-MS studies sustain the¹H-NMR result. The electronic structure of the same representative ligand was optimized using 6-311G basis set at HF level ab initio studies to predict the coordinating atoms of the ligand.     

Copper(II) Complexes with Ethyl [(Pyrazolo-1-carbothioyl)-amino]acetate Derivatives: Synthesis and Structure

Optically active derivative of the natural monoterpene (+)-3-carene, namely, ethyl (3bS,4aR)-[(3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-carbothioyl)-amino]acetate (HL¹) and ethyl [(3,5-dimethyl-pyrazole-1-carbothioyl)-amino]acetate (HL²) were synthesized. Paramagnetic complexes [CuL¹Cl] _n (I) and [Cu₂L² ₂Cl₂] (II) were prepared. According to X-ray diffraction data, complex Iwith anion of (+)-3-carene derivative has chain structure, whereas complex IIwith anion of HL², which has no carbocyclic fragments, is a pseudodimer. Organic anions act as tetradentate bridging, cyclic ligands forming five-membered CuN₃C and CuNOC₂metal cycles. Coordination polyhedron of Cu(ClN₂O + S) in complexes Iand IIis a square pyramid. The values of _efffor complexes Iand II(1.88 and 1.84 _B, respectively) are constant in the temperature interval 78–300 K, which means that the unpaired electrons of Cu(II) ions do not exhibit any noticeable exchange interactions.     

Ferric reducing, antiradical and beta-carotene bleaching activities of nicotinic acid and picolinic acid bioconjugates of curcumin

Although curcumin displays several beneficial properties, its medicinal use is limited by its low bioavailability. In the present study we report the antioxidant potentials of two bioconjugates of curcumin with nicotinic acid and picolinic acid: di-O-nicotinoyl curcumin [1,7-bis (4-O nicotinoyl-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione] and di-O-picolinoyl curcumin [1,7-bis (4-O-picolinoyl-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione], in terms of ferric reducing, radical scavenging and beta-carotene bleaching abilities, and comparing the observed activity with that of curcumin. Results demonstrate that both the bioconjugates possess higher antioxidant potentials as evidenced by enhanced ferric reducing, radical scavenging and beta-carotene bleaching abilities, in comparison with curcumin. On the basis of our results we conclude that these bioconjugates of curcumin may be better than curcumin for medicinal and pharmacological applications.